All Online

1 - 12 of 24 results

Refine

Active filters

Pain Management
0.25 CME CREDIT

Gabapentinoid Drugs Off-Label Use: Stay in Your Lane! - Frankly Speaking EP 127

Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato

0.25 CME

Join us as we discuss the increased off-label use of gabapentinoids most likely in response to the treatment of pain.


0.75 CME CREDIT

Primary care providers frequently encounter various types of chronic non-cancer pain in their practice, including chronic low back pain, chronic headache, fibromyalgia, neuropathic pain, osteoarthritis, and others. Best practices for the management of chronic non-cancer pain consist of a multimodal approach, with the optimal incorporation of non-opioid treatment approaches. This session will describe multiple approaches to non-opioid pain management for the primary care. Strategies include both pharmacologic and non-pharmacologic approaches as well as interventional approaches. Recognizing that some of these may require referral to a specialist, the primary care provider, with heightened awareness of multiple non-opioid pain management treatments, will be able to more comprehensively evaluate and treat their patients with chronic pain.


1 CME CREDIT

Marijuana has become the new fashion statement of medicine. An illegal substance that was, in recent decades, described as the gateway drug, has now found a place within the pharmaceutical industry and the doctor’s office. To prescribe or not to prescribe? This lecture will help you answer that question with information on the proposed mechanisms of action, indications for use, and risks of using medical cannabis in pain management. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 6, 2020 and they are subject to change as new information is published.


1 CME CREDIT

This talk will review the pathophysiologic mechanisms of pain and how to best address them.


1 CME CREDIT

This activity will outline current guidelines for management of various types of pain as well discuss risk management strategies when prescribing opioids.


1 CME CREDIT

This presentation will review the history and current policies related to cannabis use in California, with an emphasis on how recent legalization and ongoing medical marijuana clinics impact primary care. The faculty will review how cannabis is consumed and discuss the scientific basis of what is known about therapeutic and harmful effects. You will walk away from this session with a roadmap on how to address cannabis use in inpatient and outpatient treatment settings and how to answers questions from patients and families


1 CME CREDIT

In an increasingly litigious era of medicine, it becomes easy to over-test, over-treat, and generally over-do some basic urgent issues in the outpatient setting. This course will review some of the most common urgent outpatient complaints and evidence-based diagnostics and therapeutics that can let both you and your patient rest well without breaking the bank. We will focus on pearls for high-value care and reinforce the importance of thorough history-taking and physical exams, as they are the most valuable and least expensive tools in the clinician’s toolkit. After this review of evidence-based criteria that will allow you to proceed confidently when further management is indicated, you can reassure your patients that more isn’t always better.


The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain versus the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including non-opioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse to manage patients’ pain and medication use optimally. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).


0.25 CME CREDIT

Favorite Podcast of the Last 200! - Frankly Speaking EP 200

Guests: Susan Feeney, DNP, FNP-BC, NP-C; Jill Terrien PhD, ANP-BC; Robert Baldor, MD, FAAFP; Alan Ehrlich, MD, FAAFP Music Credit: Richard Onorato

0.25 CME

Join us for the 200th episode of Frankly Speaking about Family Medicine! In this episode, each podcaster will review their favorite topics since the inception of this podcast and will describe patient encounters where this practice changing knowledge was helpful. .


0.287 CME CREDIT

Are opioids effective in chronic pain management? Join neurologist and pain specialist, Dr. Charles Argoff, as he summarizes two recent trials published in JAMA examining the efficacy of opioids in pain management and discusses their clinical implications. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/23/2020 and they are subject to change as new information is published.


0.368 CME CREDIT

Pain Points: Best Practices for Tapering of Opioids

0.25 CME/MOC
0.37 AANP | 0.37 Pharmacology

Do you have questions about how to approach tapering opioid medications? Join neurologist and pain specialist, Dr. Charles Argoff, as he reviews a recent expert consensus statement published in Mayo Clinic Proceedings that provides guidance to clinicians about safe opioid tapering. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/23/2020 and they are subject to change as new information is published. /